Back to top
Top

["Allergy, Intolerance": "Influenza Vaccine"]

Performance/Reporting Period
2022
Value Set Description from VSAC
Clinical Focus: The purpose of this value set is to represent concepts for immunizations with influenza vaccines.
Data Element Scope: This value set may use a model element related to Immunization.
Inclusion Criteria: Includes concepts that represent an influenza vaccine.
Exclusion Criteria: No exclusions.

Constrained to codes in the Allergy, Intolerance: Influenza Vaccine 1 value set (2.16.840.1.113883.3.526.3.1254)

QDM Datatype and Definition (QDM Version 5.5 Guidance Update)

"Allergy Intolerance"

Data elements that meet criteria using this datatype should document the allergy or intolerance and its corresponding value set.

Timing:

  • The prevalence period references the time from the onset date to the abatement date. Often an abatement date is not present as allergy or intolerance is ongoing.
  • The author dateTime references the recorded time.
QDM Attributes

authorDateTime

The time the data element was entered into the clinical software. Note, some datatypes include both relevant dateTime and author dateTime attributes. When both are present, author dateTime is included to accommodate negation rationale.

The author dateTime addresses when an activity is documented. Documentation can occur at the beginning, during, at the end, or subsequent to the end of the activity. The author dateTime should be used only if the relevantPeriod cannot be obtained or to represent the time negation rationale is documented.

Note: negation rationale indicates a one-time documentation of a reason an activity is not performed. Negation of QDM datatype related actions for a reason always use the author dateTime attribute to reference timing and must not use relevantPeriod.

prevalencePeriod

Prevalance Period is the time from onset dateTime to abatement dateTime.
Last Updated: Jan 14, 2022